Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Vitruvias Therapeutics Inc., priced at $0.0787 per EA under NDC 69680015792. Its NADAC has been published 165 times since Jun 28, 2023.
FDA first approved this application on Aug 21, 2017. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Vitruvias Therapeutics Inc.NDC
69680015792
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208652FDA Approved
8/21/2017
TE Code
AB3
On Market Since
4/10/2023
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 165 times since Jun 28, 2023, and over the history we have for it it has declined 24.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0787 per EA |
|---|---|
| All-time high | $0.1215 (Apr 10, 2024) |
| All-time low | $0.0745 (Nov 20, 2024) |
| 52-week high | $0.1015 |
| 52-week low | $0.0770 |
| Median price | $0.1013 |
| Average price | $0.0982 |
| Largest weekly change | -30.3% (Nov 20, 2024) |
| Weeks tracked | 165 |
| Tracking since | Jun 28, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Vitruvias Therapeutics Inc., is $0.0787 per EA (NDC 69680015792), effective Aug 19, 2026.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 24.3%. It has been tracked across 165 weekly CMS publications since Jun 28, 2023.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Jun 28, 2023, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0745 (Nov 20, 2024) to a high of $0.1215 (Apr 10, 2024), with a median of $0.1013 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0786 per EA — about 0% below BUPROPION HCL XL 150 MG TABLET.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 69680015792) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.